Sector revisions Poolbeg Pharma PLC

Equities

Market Closed - London S.E. Other stock markets 09:05:15 20/04/2026 pm IST			5-day change	1st Jan Change
4.400 ^GBX	-4.35%		+4.76%	+10.00%

15/04	Windar hails 'strongest ever first quarter'	AN
15/04	Poolbeg Pharma Secures Topical Trial Authorization for POLB 001 Therapy in UK	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
POOLBEG PHARMA PLC	-	-		-	-	1
ARGENX SE						15
WUXI APPTEC CO., LTD.						18
INSMED INCORPORATED						20
BIONTECH SE						18
SUMMIT THERAPEUTICS INC.						14
WUXI BIOLOGICS (CAYMAN) INC.						21
AKESO, INC.						21
GENMAB A/S						14
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.						17
MADRIGAL PHARMACEUTICALS, INC.						14
EXELIXIS, INC.						18
REMEGEN CO., LTD.						15
SAMSUNG EPIS HOLDINGS CO., LTD.			-	-	-	1
ARROWHEAD PHARMACEUTICALS, INC.						11
VAXCYTE, INC.						9
NUVALENT, INC.						18
CYTOKINETICS, INCORPORATED						18
IMMUNITYBIO, INC.						5
PHARMAESSENTIA CORPORATION						7
Average						14
Weighted average by Cap.						16